• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IFN-β 改变多发性硬化症患者 T 细胞中神经营养因子的表达 - 新型神经降压素/NTSR1 通路在神经保护中的作用。

IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.

机构信息

University of Colorado School of Medicine Medical Scientist Training Program Aurora, CO, USA.

Department of Psychiatry, University of Vermont Burlington, VT, USA.

出版信息

Am J Transl Res. 2014 May 15;6(3):312-9. eCollection 2014.

PMID:24936223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058312/
Abstract

Inflammation in relapsing remitting multiple sclerosis (RRMS) is hypothesized to provide neuroprotective effects via altered cytokine/neurotrophin homeostasis. The distinct neurotrophin production from specific cell populations has not been systematically studied and is likely of high yield in understanding the complex regulation of MS pathogenesis. Here, we describe how the mainstream therapy interferon-β (IFN-β) modulates neurotrophin expression in T cells isolated from RRMS patients and characterize the neuroprotective capabilities of these factors. We utilize SuperArray gene screen technology to investigate the neurotrophin expression profile of T cells. We demonstrate that IFN-β induces an anti-inflammatory cytokine expression pattern in T cells. Additionally, IFN-β upregulates the expression of a novel neurotrophin receptor, the neurotensin high affinity receptor 1 (NTSR1). NTSR1 is expressed in active demyelinating lesions. Furthermore, we demonstrate that the receptor agonist neurotensin is a potent inducer of human neural stem/progenitor cell survival. Our findings highlight the importance of neurotrophin receptors in RRMS and offer insight into disease pathogenesis as well as the mechanisms of action of IFN-β.

摘要

在复发缓解型多发性硬化症(RRMS)中,炎症被假设通过改变细胞因子/神经营养因子的平衡来提供神经保护作用。特定细胞群产生的独特神经营养因子尚未得到系统研究,对于理解 MS 发病机制的复杂调控可能具有很高的价值。在这里,我们描述了主流治疗药物干扰素-β(IFN-β)如何调节 RRMS 患者分离的 T 细胞中的神经营养因子表达,并描述了这些因子的神经保护能力。我们利用 SuperArray 基因筛选技术来研究 T 细胞的神经营养因子表达谱。我们证明 IFN-β 在 T 细胞中诱导抗炎细胞因子表达模式。此外,IFN-β 上调了一种新型神经营养因子受体,即神经降压素高亲和力受体 1(NTSR1)的表达。NTSR1 在活跃的脱髓鞘病变中表达。此外,我们证明受体激动剂神经降压素是人类神经干细胞/祖细胞存活的有效诱导剂。我们的发现强调了神经营养因子受体在 RRMS 中的重要性,并为疾病发病机制以及 IFN-β 的作用机制提供了新的见解。

相似文献

1
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.IFN-β 改变多发性硬化症患者 T 细胞中神经营养因子的表达 - 新型神经降压素/NTSR1 通路在神经保护中的作用。
Am J Transl Res. 2014 May 15;6(3):312-9. eCollection 2014.
2
Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.干扰素-β调节细胞因子和脑源性神经营养因子:在复发型多发性硬化症中的作用大于进展型多发性硬化症。
Mult Scler. 2007 May;13(4):459-70. doi: 10.1177/1352458506069672. Epub 2007 Feb 9.
3
Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.比较干扰素-β治疗的缓解-复发型多发性硬化症患者中反应性和非反应性 Th1 和 Th17 细胞中 miR-29b-3p 和 miR-326 的表达水平。
Iran J Allergy Asthma Immunol. 2020 Aug 25;19(4):416-425. doi: 10.18502/ijaai.v19i4.4116.
4
IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.β-1b干扰素在复发缓解型多发性硬化症患者中诱导短暂且可变的基因表达,这与中和抗体或干扰素受体RNA表达的变化无关。
J Interferon Cytokine Res. 2008 May;28(5):317-31. doi: 10.1089/jir.2007.0131.
5
Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.继发进展型多发性硬化症中独特的趋化因子受体和细胞因子表达谱
Neurology. 2001 Oct 23;57(8):1371-6. doi: 10.1212/wnl.57.8.1371.
6
Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.干扰素-β1b对多发性硬化症患者T细胞中CXCR4依赖性趋化作用的影响。
Clin Exp Immunol. 2015 Nov;182(2):162-72. doi: 10.1111/cei.12689. Epub 2015 Aug 31.
7
The role of endogenous IFN-β in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis.内源性 IFN-β 在调节复发缓解型多发性硬化症患者 Th17 反应中的作用。
J Immunol. 2014 Jun 15;192(12):5610-7. doi: 10.4049/jimmunol.1302580. Epub 2014 May 21.
8
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.干扰素(IFN)-β治疗可增强多发性硬化症患者的CD95和白细胞介素10表达,但减少产生干扰素-γ的T细胞。
J Neuroimmunol. 1999 Apr 1;96(1):92-100. doi: 10.1016/s0165-5728(98)00271-9.
9
Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.免疫细胞中神经营养因子 mRNA 产生失调与复发缓解型多发性硬化症有关。
J Neurol Sci. 2010 Aug 15;295(1-2):31-7. doi: 10.1016/j.jns.2010.05.019. Epub 2010 Jun 11.
10
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.复发缓解型和继发进展型多发性硬化症患者在接受β-干扰素治疗期间的神经营养因子
Clin Immunol. 2006 Jan;118(1):77-82. doi: 10.1016/j.clim.2005.09.005. Epub 2005 Nov 7.

引用本文的文献

1
Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis.良性多发性硬化症患者的光学相干断层扫描与T细胞基因表达分析
Neural Regen Res. 2017 Aug;12(8):1352-1356. doi: 10.4103/1673-5374.213558.
2
Neutrophils Induce Astroglial Differentiation and Migration of Human Neural Stem Cells via C1q and C3a Synthesis.中性粒细胞通过C1q和C3a的合成诱导人神经干细胞的星形胶质细胞分化和迁移。
J Immunol. 2017 Aug 1;199(3):1069-1085. doi: 10.4049/jimmunol.1600064. Epub 2017 Jul 7.
3
The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis.血管紧张素转化酶基因插入/缺失多态性与多发性硬化症尼古丁依赖之间缺乏关联。
Brain Behav. 2016 Nov 14;7(1):e00600. doi: 10.1002/brb3.600. eCollection 2017 Jan.
4
Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathway.干扰素β(IFN-β)治疗通过神经营养因子和新的神经降压素/神经降压素高亲和力受体1途径发挥潜在的神经保护作用。
Neural Regen Res. 2015 Dec;10(12):1932-3. doi: 10.4103/1673-5374.169636.

本文引用的文献

1
Interferon β-1b directly modulates human neural stem/progenitor cell fate.干扰素β-1b 直接调节人神经干细胞/祖细胞的命运。
Brain Res. 2011 Sep 21;1413:1-8. doi: 10.1016/j.brainres.2011.07.037. Epub 2011 Jul 23.
2
Cross-talk between CD4+ T-cells and neural stem/progenitor cells.CD4+T 细胞与神经干细胞/祖细胞间的对话。
J Neurol Sci. 2011 Jul 15;306(1-2):121-8. doi: 10.1016/j.jns.2011.03.030. Epub 2011 Apr 14.
3
Histology of the central nervous system.中枢神经系统组织学
Toxicol Pathol. 2011 Jan;39(1):22-35. doi: 10.1177/0192623310389621. Epub 2010 Nov 30.
4
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.骨桥蛋白浓度在多发性硬化症发作期间增加在脑脊液中。
Mult Scler. 2011 Jan;17(1):32-42. doi: 10.1177/1352458510382247. Epub 2010 Oct 4.
5
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.视神经脊髓炎的细胞因子和趋化因子谱:白细胞介素-6 的意义。
Mult Scler. 2010 Dec;16(12):1443-52. doi: 10.1177/1352458510379247. Epub 2010 Aug 25.
6
Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis.多发性硬化症患者外周血免疫细胞中脑源性神经营养因子的产生改变。
Mult Scler. 2010 Oct;16(10):1178-88. doi: 10.1177/1352458510375706. Epub 2010 Jul 23.
7
Fas activation increases neural progenitor cell survival.Fas 激活可增加神经祖细胞的存活率。
J Neurosci Res. 2010 Mar;88(4):746-57. doi: 10.1002/jnr.22253.
8
Serum levels of CXCL13 are elevated in active multiple sclerosis.血清 CXCL13 水平在活动期多发性硬化症中升高。
Mult Scler. 2009 Nov;15(11):1271-9. doi: 10.1177/1352458509107017. Epub 2009 Oct 5.
9
The therapeutic potential of neural stem cells.神经干细胞的治疗潜力。
Nat Rev Neurosci. 2006 May;7(5):395-406. doi: 10.1038/nrn1908.
10
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.复发缓解型和继发进展型多发性硬化症患者在接受β-干扰素治疗期间的神经营养因子
Clin Immunol. 2006 Jan;118(1):77-82. doi: 10.1016/j.clim.2005.09.005. Epub 2005 Nov 7.